Shares of Oklo Inc. slid 7% to $68.35 on June 3, retreating sharply after a blistering 9.7% single-day surge on June 1 that was itself fueled by weeks of compounding regulatory wins. Trading activity reflects ongoing profit-taking and sector-wide selling pressure , but no new negative news has surfaced. The question for shareholders: does a pre-revenue nuclear startup with an ~$11.7 billion market cap deserve the benefit of the doubt — or has enthusiasm gotten ahead of execution?
A Week of Catalysts Set the Stock on Fire — Then Gravity Kicked In
Oklo was selected by the U.S. Department of Energy on May 26 for advanced negotiations under the Surplus Plutonium Utilization Program, which aims to convert surplus government plutonium into fuel for advanced reactors. That followed the NRC's May 6 approval of Oklo's key design criteria for its Idaho reactor and Oklo's first-ever NRC license, granted in March to its subsidiary for isotope handling — a milestone marking the shift from planning to real-world execution. Each headline stacked buying pressure. The reversal today is the market digesting a cluster of good news all at once.
Both Co-Founders Sold 400,000 Shares on the Way Up
CEO Jacob DeWitte sold 200,000 shares on June 1 at prices between $64.99 and $70.45 under a pre-arranged trading plan set in March 2025.
COO Caroline Cochran sold an identical 200,000 shares the same day under the same type of plan. Pre-scheduled or not, 400,000 shares hitting the market during a momentum rally adds supply. DeWitte retains roughly 16 million shares across family trusts , so conviction isn't in doubt — but the optics amplify today's selloff.
$2.5 Billion in Cash Buys Time, Not Revenue
Oklo ended Q1 with approximately $2.5 billion in cash and securities — a 92% jump from the prior quarter — giving it ample runway. Yet its net loss widened to $33.1 million from $9.8 million a year earlier , and analysts project just $51.8 million in revenue by 2029. That means today's valuation prices in years of flawless execution.
The Real Test Is Turning Permits Into Power
Regulatory progress is necessary but not sufficient — investors still need evidence Oklo can convert approvals into a credible project timeline with commercial weight.
The DOE selection strengthens federal ties but does not remove near-term execution risk around licensing, construction, and converting its 14-gigawatt pipeline into binding agreements.
The consensus price target sits at $86.30, implying roughly 28% upside — but that estimate rests on milestones that haven't happened yet.